NANUET, NY -- (Marketwired) -- 10/02/13 -- The Board of Directors has unanimously appointed Mr. Robert McDermott on July 3rd, 2013 to become iMedicor's (OTC Pink: VMCI) new President & CEO. The Board selected Mr. McDermott because of his proven track record of successfully building and operating profitable companies. Over the course of his career he has demonstrated strong executive and leadership skills. This exciting managerial appointment by iMedicor is expected to transition the company from a development-stage company to a Sales and Operating company.
Mr. McDermott stated, "I am excited to join iMedicor along with a seasoned management team that has worked with me for numerous years. My team and I look forward to the opportunity to build iMedicor into a profitable and successful organization. We will immediately be implementing changes with respect to how we go to market and how we achieve our vision to create significant value for our customers. We have expanded our geographic territory predominately from the Northeast to a national footprint by increasing the scope and reach of our sales and support effort. I am looking forward to the challenges that lie ahead. Our first priority is to increase our customer base that will result in revenue growth and eventual profitability."
iMedicor, Inc. (OTC Pink: VMCI) is a national provider of comprehensive secure communications solutions for the healthcare community. iMedicor offers physicians and other healthcare professionals the use of a HIPAA-compliant communications network that addresses current federal standards for security and Interoperability. iMedicor also serves as one of the country's leading Meaningful Use consultants to assist doctors and dentists with conversion from paper to electronic health records (EHRs) and qualifying under Medicare and Medicaid guidelines for Federal Incentive Funding.
Statements made in this press release that are not historical in nature constitute forward-looking statements within the meaning of the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Such statements are based on the current expectations and beliefs of the management of iMedicor. No forward-looking statement can be guaranteed. iMedicor undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect iMedicor's business.